SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,844,000 | +4.5% | 18,904 | -0.6% | 0.00% | 0.0% |
| Q4 2014 | $1,764,000 | +31.8% | 19,013 | -2.3% | 0.00% | 0.0% |
| Q3 2014 | $1,338,000 | -31.7% | 19,456 | +4.0% | 0.00% | 0.0% |
| Q2 2014 | $1,960,000 | +40.3% | 18,702 | +11.1% | 0.00% | 0.0% |
| Q1 2014 | $1,397,000 | +19.9% | 16,840 | -6.4% | 0.00% | +100.0% |
| Q4 2013 | $1,165,000 | +1.7% | 18,000 | -0.4% | 0.00% | 0.0% |
| Q3 2013 | $1,145,000 | +57.1% | 18,080 | +6.5% | 0.00% | 0.0% |
| Q2 2013 | $729,000 | – | 16,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|